PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23362262-6	2013	Using the mTOR inhibitor PP242, we found that TGFbeta-induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression.	PP242	25-30	CREB regulated transcription coactivator 2	Homo sapiens	111-116	
20686120-3	2010	To assess if the mammalian target of rapamycin within the TORC2 complex could be a better target in MM, we tested a new agent, pp242, which prevents activation of TORC2 as well as TORC1.	PP242	127-132	CREB regulated transcription coactivator 2	Homo sapiens	58-63	
20686120-3	2010	To assess if the mammalian target of rapamycin within the TORC2 complex could be a better target in MM, we tested a new agent, pp242, which prevents activation of TORC2 as well as TORC1.	PP242	127-132	CREB regulated transcription coactivator 2	Homo sapiens	163-168	
20686120-4	2010	Although comparable to rapamycin against phosphorylation of the TORC1 substrates p70S6kinase and 4E-BP-1, pp242 could also inhibit phosphorylation of AKT on serine 473, a TORC2 substrate, while rapamycin was ineffective.	PP242	106-111	CREB regulated transcription coactivator 2	Homo sapiens	171-176	
20072130-3	2010	We compared rapamycin with PP242, an inhibitor of the active site of mTOR in both TORC1 and TORC2 (hereafter referred to as TORC1/2), in models of acute leukemia harboring the Philadelphia chromosome (Ph) translocation.	PP242	27-32	CREB regulated transcription coactivator 2	Homo sapiens	92-97	
20072130-3	2010	We compared rapamycin with PP242, an inhibitor of the active site of mTOR in both TORC1 and TORC2 (hereafter referred to as TORC1/2), in models of acute leukemia harboring the Philadelphia chromosome (Ph) translocation.	PP242	27-32	CREB regulated transcription coactivator 2	Homo sapiens	124-131